Rocket Lab Corporation (RKLB) is poised for a crucial trading session on Tuesday as U.S. markets reopen following the Memorial Day holiday. The stock surged 8.22% on Friday, closing at $135.76, buoyed by a significant $90 million contract from the U.S. Space Force and a flawless Electron rocket launch for Synspective. However, investor enthusiasm is tempered by the company's disclosure of a potential $3 billion at-the-market stock offering, which could dilute existing shareholders.
Defense and Launch Milestones Drive Momentum
On May 21, Rocket Lab announced it had secured a $90 million contract from the U.S. Space Force to design, build, integrate, and operate two geostationary satellites equipped with Heimdall space-domain-awareness payloads. Geostationary orbit allows satellites to maintain a fixed position relative to the Earth's surface, making them ideal for persistent monitoring and communications. The contract underscores Rocket Lab's expanding role in national security space programs.
The following day, the company completed its ninth Electron mission for Synspective, deploying a StriX synthetic aperture radar (SAR) satellite into a 572-kilometer orbit from its New Zealand launch site. SAR technology enables high-resolution imaging through cloud cover and darkness, making it valuable for defense and commercial applications. Rocket Lab has a backlog of 18 additional launches for Synspective, highlighting the strength of its small launch business.
Financial Performance and Dilution Concerns
Rocket Lab's first-quarter results support the recent rally. Revenue surged 63.5% year-over-year to $200.3 million, with a record backlog of $2.2 billion. The company expects second-quarter revenue between $225 million and $240 million, though it still anticipates an adjusted EBITDA loss of $20 million to $26 million. EBITDA, or earnings before interest, taxes, depreciation, and amortization, is a proxy for operating cash flow.
Despite the strong top-line growth, a recent Securities and Exchange Commission filing revealed that Rocket Lab could sell up to $3 billion in common stock through an at-the-market offering. This program allows the company to issue shares into the open market at prevailing prices, potentially diluting existing shareholders and pressuring the stock. The filing explicitly noted the risk of earnings per share dilution.
SpaceX IPO Casts Spotlight on Public Space Stocks
The broader space sector is also drawing attention from SpaceX's reported Nasdaq IPO filing. Wedbush analyst Dan Ives described the move as placing SpaceX at the center of "two of the largest growth opportunities" over the coming decades. While a SpaceX debut could spark interest in publicly traded space companies like Rocket Lab, some analysts caution that SpaceX's massive valuation might overwhelm the market.
Lukas Muehlbauer, research associate at IPOX, told Reuters that SpaceX is "so large and extraordinarily valued" that it is not a typical IPO test case. Brian Jacobsen of Annex Wealth Management noted that retail investors "can be pulled in by how monumental this may be."
Market Context and Competitive Landscape
On Friday, other space stocks also rallied. AST SpaceMobile and Virgin Galactic both posted gains of over 9%, while Firefly Aerospace and Rocket Lab moved higher after prior declines. Rocket Lab's business model, focused on small launch, spacecraft systems, and defense, differentiates it from AST's communications focus and Virgin Galactic's space tourism ambitions.
The broader market provided a tailwind, with the S&P 500 logging its eighth consecutive weekly gain, the longest such streak since late 2023. A firm Nasdaq tends to lift high-growth, loss-making names like Rocket Lab.
Outlook and Key Risks
Rocket Lab's current valuation reflects high expectations. The company's future beyond small launch depends on the development of Neutron, a larger reusable rocket still in progress, as well as new defense and satellite manufacturing contracts that must generate revenue without cost overruns. "But, you know, stuff could go wrong," University of Florida professor Jay Ritter told Reuters, emphasizing the risks for companies with elevated price-to-sales ratios.
Tuesday's session will test whether Friday's bounce can sustain momentum or whether the $3 billion share-sale overhang and questions about SpaceX's market impact will pull the stock lower.
